A Study of TAK-881 and HyQvia in Healthy Adults

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
The main aim of this study is to understand how the body absorbs, processes, and removes (known as pharmacokinetics or PK) TAK-881 and HyQvia, after they are given as a single injection under the skin in healthy adults. Study participants will receive a single dose of TAK-881 or HyQvia on Day 1. During the study, participants will need to stay at the clinic for 8 days followed by 8 ambulatory follow up visits till Day 85.
Epistemonikos ID: 498e551babe1917d43b99698c7482b3405f43f27
First added on: Mar 27, 2025